Caligula or Pee-Wee Herman?

Trump isn’t a jobs creator—the jobs reports are down. So what does Trump do? He fires the Commissioner of Labor Statistics. How many jobs will shooting the messenger create?

Meanwhile, his threatened tariffs have stocks headed down. Will he fire Wall Street?

A fed governor steps down, making room for a Trump appointment and setting the stage for a Trump takeover of the Fed. When inflation spirals out of control because of Trump rate cuts, who will he fire?

Meanwhile, Trump is being played by his counterparties in tariff negotiations:

““They’re playing Trump,” said C. Fred Bergsten, a renowned economist who served on the Advisory Committee on Trade Policy and negotiations under both presidents Barack Obama and Trump. “They’re giving him a talking point that he can use to characterize his agreements as big deals with big pay offs, but there’s no ‘there’ there.”

 

“Contrary to accounts of Trump’s “triumphant” performance in trade negotiations, “America is a loser from all of Trump’s trade deals,” said Bergsten, who also served as the founding director of the Peterson Institute for International Economics. 

 

“In recent days, Trump has trumpeted multibillion-dollar investments that foreign governments have pledged to put into the U.S. economy, including two separate $750 billion and $600 billion pledges from the EU, a $550 executive account funded by Japan, $350 billion from South Korea. These flashy numbers don’t tell the whole story.

 

“It’s ludicrous to think that these market economies would be able to fulfill such commitments,” said Bergsten.

 

“In a late July release, the White House claimed the 27 member states that make up the EU “will purchase $750 billion in U.S. energy” over the next three years, along with $600 billion in additional investments. Almost immediately, the European Commission contradicted that alleged commitment. Euronews itemized a list of conflicting accounts, ranging from the tariff rate on pharmaceuticals to the pledges to purchase U.S. military equipment, a pledge Euronews reported the EU “resolutely denied.” 

It’s our economy. It’s our dollar. It’s our cost of living. It’s our national stature. It’s our future. He’s burning it all to the ground. We’re in the burning house, peeps.

 

https://talkingpointsmemo.com/news/experts-say-foreign-governments-are-playing-trump-on-tariffs

Comments

Post a Comment

Popular posts from this blog

The ruble is collapsing

In 1998, I traveled to Moscow for the first time to teach in a summer course at the Russian Academy. The week before, we were on vacation and I heard on the radio “Today, the ruble lost 100% of its value.” This news was arresting—it meant that the ruble was worthless. That seemed unlikely. Indeed, the next day, the announcer apologized and said she meant to say that the ruble lost 50% of its value.  In the event, by the time I arrived at the Hotel Sputnik in Moscow, all the cash machines in the city were shut down. Restaurant prices changed hourly during my five-day stay, and there were sidewalk signs posting exchange rates that were written in chalk so they could easily be edited. Certainly puts our recent experience with inflation in perspective.   Over at jabberwocking.com, Kevin Drum notes that the ruble is down 30% since the war started and 20% just since September.   From the comment thread: “The problem with the Russian economy at this point is that it is basically...
Read more

Saving Ryan

I just finished reading “Saving Ryan” by Emil Kakkis. Kakkis is a physician who pioneered enzyme replacement therapy for Mucopolysaccharidosis I (MPS I), a progressive and fatal disease. The story is about the patients and their families who struggle with the disease and Emil’s struggle to deliver life-enhancing therapy against terribly long odds. The Ryan of the book’s title is a kid with MPS I. His working class parents were not content to watch Ryan decline and die in his first or second decade. MPS I is an extremely rare disease, so big pharma sees no potential for return on investment for developing treatments or cures. Ryan’s parents start a foundation to raise money for a cure. I seldom read lay science/medical books because they usually spend too much time explaining technical details that I already understand, and I find myself wincing at the imprecision and outright errors. This book avoids that pitfall, both by being scientifically sound and concise, and by keeping the f...
Read more

The price of Trump’s war on universities

  For decades, the United States has been the world leader in scientific research. Even as China has been catching up, the US has managed to remain a magnet for scientists world-wide, and its universities are the most desirable destinations for undergrads and graduate students. Until now. “ There are significant economic consequences to spiking medical research in the universities: this subsidizes the training of people who will work in the industry, and it drives the types of blue sky research that industry doesn’t want to do, but that it benefits greatly from. It creates a vacuum that other countries will rush to fill. If it persists, the comparative advantage that the US has gained by attracting top global talent will collapse.     “At the same time, what Trump and his cronies are doing to the education system with their anti-science agenda will pretty much guarantee that home grown talent is likely to be non-competitive globally. As the split with Musk over visas indi...
Read more